Abstract
Between 1965 and 1988 there were 2953 patients with papillary carcinoma treated at Noguchi Thyroid Clinic. Among them 761 patients were excluded because the primary tumor was <10 mm in maximum diameter, the patient's age was >80, or the patient underwent noncurative surgery. The remaining 2192 patients, 192 men and 2000 women, were analyzed. The mean follow-up period was 12.5 years. Total thyroidectomy, subtotal thyroidectomy, lobectomy with or without isthmectomy, and less than lobectomy were performed in 2.3%, 40.3%, 44.2%, and 13.2%, respectively. Modified radical neck dissection, partial node excision, and no node excision were performed in 77.8%, 6.4%, and 15.8%, respectively. Men and women were separately analyzed because their risk factors and prognosis were significantly different. Multivariate analysis was carried out according to Cox's regression hazard model. Independently significant factors affecting prognosis in men were aged and gross nodal metastasis; and age, gross nodal metastasis,tumor size, and number of adhered tissues or organs were the factors in women. Based on those risk factors patients were classified into three groups. For men, 65.6% were classified in the excellent group and their 10-year survival was 98.4%; 17.2% were classified as intermediate and 17.2% as poor with survival rates of 90.1% and 74.4%, respectively. For female patients 69.6% were classified in the excellent group, 18.6% in the intermediate group, and 11.9% in the poor group with 10-year survivals of 99.3%, 96.4%, and 88.8%, respectively.
Résumé
Entre 1965 et 1988, 2953 patients ayant un cancer papillaire de la thyroïde ont été opérés à la Clinique Noguchi. Parmi ceux-ci, il y avait 761 cas où soit la tumeur primitive était inférieure à 10 mm de diamètre, soit le patient était âgé de plus de 80 ans ou encore avait eu une chirurgie non curative: ceux-là n'ont pas été étudiés ici. Parmi les 2192 autres, 2000 femmes et 192 hommes, le suivi moyen a été de 12.5 ans. Une thyroïdectomie totale, subtotale, une lobectomie enlevant aussi l'isthme ou pas et une exérèse partielle d'un lobe ont été effectuée dans 2.3%, 40.3%, 44.2%, et 13.2% des cas, respectivement. Un curage cervical, une lymphadenectomie partielle ou aucune lymphadenectomie cervicale a été pratiqué dans respectivement 77.8%, 8.4% et 15.8% des cas Les hommes et les femmes ont été analysés séparément en raison de leur facteurs de risque et facteurs pronostiques très différents. L'analyse multifactorielle a été menée selon le modèle de Cox. Les facteurs indépendants influencant de façon significative le pronostic ont été l'âge et les métastases macroscopiques chez l'homme, l'âge, les métastases macroscopiques, la taille de la tumeur et nombres de organes adhérents à la tumeur chez la femme. En se basant sur ces données, les patients ont été classés en trois groupes. 65.6% des hommes ont été classés dans le groupe “pronostic excellent”: leur survie à 10 ans était de 98.4%. 17.2% ont été classés comme “pronostic intermédiaire” et 17.2% comme “pronostic mauvais” avec des survies à 10 ans de 90.1% et de 74.4%, respectivement. Les chiffres pour la femme ont été, respectivement, de 99.3%, 96.4% et 88.8%.
Resumen
Entre 1965 y 1988, 2.953 pacientes con carcinoma papilar fueron tratados en la Clínica de Tiroides de Noguchi. De éstos, 761 fueron excluídos porque el tumor primario era menor de 10 mm en su diámetro máximo, porque su edad era superior a los 80 años o por haber recibido cirugía no curativa; los 2.192 pacientes restantes—192 hombres y 2.000 mujeres-fueron estudiados. El promedio del seguimiento fue 12.5 años. Se practicó tiroidectomía total, tiroidectomía subtotal, lobectomía con o sin istmectomía y lobectomía parcial en 2.3%, 40.3%, 44.2% y 13.2% respectivamente. Se practicó disección radical modificada del cuello, resección ganglionar parcial y ninguna disección ganglionar en 77.8%, 6.4% y 15.8%, respectivamente.
Los hombres y las mujeres fueron analizados por separado por cuanto sus factores de riesgo y pronóstico aparecieron significativamente diferentes. El análisis multivariable fue realizado de acuerdo con el modelo de regresión de riesgo de COX. Los factores independiente de significación relativa al pronóstico en los pacientes masculinos fueron la edad y las metástasis ganglionares macroscópicas; y la edad, las metástasis ganglionares macroscópicas, el tamaño del tumor y el número de tejidos/órganos adheridos en las del sexo femenino.
Con base en los factores de riesgo, los pacientes fueron clasificados en tres grupos: 65.6% de los pacientes masculinos quedaron clasificados en el grupo excelente y su tasa de sobrevida fue de 98.4%, 17.2% fueron clasificados como intermedios y 17.2% como pobres, con sobrevidas de 90.1% y 74% respectivamente. En los pacientes femeninos, 69.9% fueron clasificados en el grupo excelente, 18.6% en el intermedio y 11.9% en el pobre, con tasas de sobrevida a 10 años de 99.3%, 96.4% y 88.8% respectivamente.
Similar content being viewed by others
References
Russell, W.O., Ibanez, M.L., Clark, R.L., White, E.C.: Thyroid carcinoma: classification, intraglandular dissemination, and clinicopathologic study based upon whole organ sections of 80 glands. Cancer 16:1425, 1963
Meissner, W.A., Colock, B.B., Achenbach, H.: The pathologic evaluation of radical neck dissection for carcinoma of the thyroid gland. J. Clin. Endocrinol. Metab. 15:1432, 1955
Noguchi, S., Noguchi, A., Murakami, N.: Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26:1053, 1970
Attie, J.N., Khafif, R.A., Steckler, R.M.: Elective neck dissection in papillary carcinoma of the thyroid. Am. J. Surg. 122:464, 1971
Roka, R., Niederle, B., Rath, T., Wenzl, E., Krisch, K., Frisch, A.: Die Bedeutung der beidseitigen diagnostischen Lymphadenectomie beim Schlddrüsencarcinom: operationstaktisches Vorgehen beim Ersteingriff. Chirurg 53:499, 1982
Ozaki, O., Ito, K., Kobayashi, K., Suzuki, A., Manabe, Y.: Modified neck dissection for patients with non-advanced, differentiated carcinoma of the thyroid. World J. Surg. 12:825, 1988
Cady, B., Sedwick, C.E., Meissner, W.A., Wool, M.S., Salzman, F.A., Weber, J.: Risk factor analysis in differentiated thyroid carcinoma. Cancer 43:810, 1979
Hay, I.D., Grant, C.S., Taylor, W.F., McConahey, W.M.: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 162:1088, 1987
Verheul, H.A., Dekker, E., Bossuyt, P., Moulijn, A.C., Dunning, A.J.: Background mortality in clinical survival studies. Lancet 347:872, 1993
Cox, D.R.: Regression models and life tables. J. R. Stat. Soc. B 34:187, 1972
Kaplan, E.L., Meier, P.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457, 1958
Rossi, R.L., Cady, B., Silverman, M.L., Wool, M.S., Horner, T.A.: Current results of conservative surgery for differentiated thyroid carcinoma. World J. Surg. 10:612, 1986
Sakamoto, A., Kasai, N., Sugano, H.: Poorly differentiated carcinoma of the thyroid: a clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849, 1983
Tourniaire, J., Bernard-Auger, M.H., Adeleine, P., Milan, J.J., Fleury-Goyon, M.C., Dutrieux-Berger, N.: Les éléments du prognostic des cancers thyroïdiens différenciés. Ann. Endocrinol. (Paris) 50:219, 1989
Simpson, W., McKinney, S.E., Carruthers, J.S., Gospodarowicz, M.K., Sutcliffe, S.B., Panzarella, T.: Papillary and follicular thyroid cancer: prognostic factors in 1578 patients. Am. J. Med. 83:479, 1987
Noguchi, S., Murakami, N.: The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg. Clin. North Am. 67:251, 1987
Noguchi, S., Noguchi, A., Murakami, N.: Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision. Cancer 26:251, 1987
Wanebo, H.J., Andrews, W., Kaiser, D.L.: Thyroid cancer: some basic consideration. Am. J. Surg. 142:474, 1981
Hamming, J.F., van de Velde, C.J.H., Gosling, B.M., et al.: Preoperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid. Surg. Gynecol. Obstet. 169:107, 1989
Buckwalter, J.A., Thomas, C.G.: Selection of surgical treatment for well-differentiated thyroid carcinomas. Ann. Surg. 176:565, 1972
Ito, J., Noguchi, S., Murakami, N., Noguchi, A.: Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg. Gynecol. Obstet. 150:539, 1980
Rosen, I.B., Maitland, A.: Changing the operative strategy for thyroid cancer by node sampling. Am. J. Surg. 146:504 1983
McConahey, W.M., Hay, I.D., Woolner, L.B., van Heerden, J.A., Taylor, W.F.: Papillary thyroid cancer treated at Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin. Proc. 61:978, 1986
DeGroot, L.J., Kaplan, E.L., McCormick, M., Straus, F.H.: Natural history, treatment, and course of papillary thyroid carcinomasa. J. Clin. Endocrinol. Metab. 71:414, 1990
Coburn, M.C., Wanebo, H.J.: Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am. J. Surg. 164:671, 1992
Carcangiu, M.L., Zampi, G., Pupi, A., Castagnoli, A., Rosai, J.: Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55: 805, 1985
Tubiana, M., Schlumberger, M., Rougier, P., et al.: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794, 1985
McHenry, C.R., Rosen, I.B., Walfish, P.G.: Prospective management of nodal metastases in differentiated thyroid cancer. Am. J. Surg. 162:353, 1991
Vickery, A.L., Wang, C.A., Walker, A.M.: Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 66:2587, 1987
Kerr, D.J., Burt, A.D., Boyle, P., MacFarlane, G.J., Storer, A.M., Brewin, T.B.: Prognostic factors in thyroid tumor. Br. J. Cancer 54:475, 1986
Rösler, H., Birrer, A., Lüscher, D., Kinser, J.: Langzeitverläufe beim differenzierten Schilddrüsenkarzinom. Schweiz. Med. Wochenschr. 122:1843, 1992
Harwood, J.H., Clark, O.H., Dunphy, J.E.: Significance of lymph node metastasis in differentiated thyroid cancer. Am. J. Surg. 136:107, 1978
Mazzaferri, E.L., Young, R.L., Oertel, J.E., Kemmerer, W.T., Page, C.P.: Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56:171, 1977
Farrar, W.B., Cooperman, M., James, A.G.: Surgical management of papillary and follicular carcinoma of the thyroid. Ann. Surg. 192:701, 1980
Hoie, J., Stenwig, A.E., Brennhovd, I.O.: Surgery in papillary carcinoma: a review of 730 patients. J. Surg. Oncol. 37:147, 1988
Cunningham, M.P., Duda, R.B., Recant, W., Chmiel, J.S., Sylvester, J., Fremgen, A.: Survival discriminant for differentiated thyroid cancer. Am. J. Surg. 166:344, 1990
Grant, C.S., Hay, I.D., Gough, I.R., Bergstrahl, E.J., Goellner, J.R., McConahey, W.M.: Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important. Surgery 164: 954, 1988
Samaan, N.A., Maheshwari, Y.K., Nader, S., et al.: Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J. Clin. Endocrinol. Metab. 56:1131, 1983
Thoresen, S.O., Akslen, L.A., Glattre, E., Haldorsen, T., Lund, E.V., Schoultz, M.: Survival and prognostic factors in differentiated thyroid cancer—a multivariate analysis of 1,055 cases. Br. J. Cancer 59:231, 1989
Hannequin, P., Liehn, J.C., Delisle, M.J.: Multifactorial analysis of survival in thyroid cancer: pitfalls of applying the results of published studies to another population. Cancer 58:1749, 1986
Fourquet, A., Asselain, B., Joly, J.: Cancer de la thyroïde: analyse multidimentionelle des facteurs prognostiques. Ann. Endocrinol. (Paris) 44:121, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Noguchi, S., Murakami, N. & Kawamoto, H. Classification of papillary cancer of the thyroid based on prognosis. World J. Surg. 18, 552–557 (1994). https://doi.org/10.1007/BF00353763
Issue Date:
DOI: https://doi.org/10.1007/BF00353763